170 related articles for article (PubMed ID: 26494532)
1. In silico studies on the role of mutant Y337A to reactivate tabun inhibited mAChE with K048.
Chandar NB; Ghosh S; Lo R; Banjo S; Ganguly B
Chem Biol Interact; 2015 Dec; 242():299-306. PubMed ID: 26494532
[TBL] [Abstract][Full Text] [Related]
2. The reactivation of tabun-inhibited mutant AChE with Ortho-7: steered molecular dynamics and quantum chemical studies.
Lo R; Chandar NB; Ghosh S; Ganguly B
Mol Biosyst; 2016 Apr; 12(4):1224-31. PubMed ID: 26879641
[TBL] [Abstract][Full Text] [Related]
3. Can hydroxylamine be a more potent nucleophile for the reactivation of tabun-inhibited AChE than prototype oxime drugs? An answer derived from quantum chemical and steered molecular dynamics studies.
Lo R; Ganguly B
Mol Biosyst; 2014 Jul; 10(9):2368-83. PubMed ID: 24964273
[TBL] [Abstract][Full Text] [Related]
4. Revealing the importance of linkers in K-series oxime reactivators for tabun-inhibited AChE using quantum chemical, docking and SMD studies.
Ghosh S; Chandar NB; Jana K; Ganguly B
J Comput Aided Mol Des; 2017 Aug; 31(8):729-742. PubMed ID: 28646405
[TBL] [Abstract][Full Text] [Related]
5. Oxime-assisted reactivation of tabun-inhibited acetylcholinesterase analysed by active site mutations.
Katalinić M; Šinko G; Maček Hrvat N; Zorbaz T; Bosak A; Kovarik Z
Toxicology; 2018 Aug; 406-407():104-113. PubMed ID: 29772260
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
[TBL] [Abstract][Full Text] [Related]
7. Counteracting tabun inhibition by reactivation by pyridinium aldoximes that interact with active center gorge mutants of acetylcholinesterase.
Kovarik Z; Maček Hrvat N; Kalisiak J; Katalinić M; Sit RK; Zorbaz T; Radić Z; Fokin VV; Sharpless KB; Taylor P
Toxicol Appl Pharmacol; 2019 Jun; 372():40-46. PubMed ID: 30978400
[TBL] [Abstract][Full Text] [Related]
8. Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase.
Ekström F; Akfur C; Tunemalm AK; Lundberg S
Biochemistry; 2006 Jan; 45(1):74-81. PubMed ID: 16388582
[TBL] [Abstract][Full Text] [Related]
9. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
Kuca K; Cabal J
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S59-61. PubMed ID: 15141981
[TBL] [Abstract][Full Text] [Related]
10. Centrally acting oximes in reactivation of tabun-phosphoramidated AChE.
Kovarik Z; Maček N; Sit RK; Radić Z; Fokin VV; Barry Sharpless K; Taylor P
Chem Biol Interact; 2013 Mar; 203(1):77-80. PubMed ID: 22960624
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the ability of a new bispyridinium oxime--1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
Kuca K; Kassa J
J Enzyme Inhib Med Chem; 2003 Dec; 18(6):529-35. PubMed ID: 15008517
[TBL] [Abstract][Full Text] [Related]
12. Catalytic-site conformational equilibrium in nerve-agent adducts of acetylcholinesterase: possible implications for the HI-6 antidote substrate specificity.
Artursson E; Andersson PO; Akfur C; Linusson A; Börjegren S; Ekström F
Biochem Pharmacol; 2013 May; 85(9):1389-97. PubMed ID: 23376121
[TBL] [Abstract][Full Text] [Related]
13. Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates.
Ekström F; Pang YP; Boman M; Artursson E; Akfur C; Börjegren S
Biochem Pharmacol; 2006 Aug; 72(5):597-607. PubMed ID: 16876764
[TBL] [Abstract][Full Text] [Related]
14. Differential binding of bispyridinium oxime drugs with acetylcholinesterase.
Kesharwani MK; Ganguly B; Das A; Bandyopadhyay T
Acta Pharmacol Sin; 2010 Mar; 31(3):313-28. PubMed ID: 20140002
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z
Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122
[TBL] [Abstract][Full Text] [Related]
16. Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochemistry; 2004 Mar; 43(11):3222-9. PubMed ID: 15023072
[TBL] [Abstract][Full Text] [Related]
17. Novel acetylcholinesterase reactivator--oxime K048--reactivation activity in vitro.
Kuca K; Marek J; Karasova J; Pohanka M; Korabecny J; Kalasz H
Med Chem; 2010 Jan; 6(1):1-5. PubMed ID: 20402654
[TBL] [Abstract][Full Text] [Related]
18. Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning.
Kovarik Z; Calić M; Sinko G; Bosak A; Berend S; Vrdoljak AL; Radić B
Chem Biol Interact; 2008 Sep; 175(1-3):173-9. PubMed ID: 18501341
[TBL] [Abstract][Full Text] [Related]
19. Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
Grosfeld H; Barak D; Ordentlich A; Velan B; Shafferman A
Mol Pharmacol; 1996 Sep; 50(3):639-49. PubMed ID: 8794905
[TBL] [Abstract][Full Text] [Related]
20. The cholinergic and non-cholinergic effects of organophosphates and oximes in cultured human myoblasts.
Katalinić M; Miš K; Pirkmajer S; Grubič Z; Kovarik Z; Marš T
Chem Biol Interact; 2013 Mar; 203(1):144-8. PubMed ID: 23047024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
